• Neuroprotective effects of ZL006 in Aβ1–42-treated neuronal cells
  Catalog No.:BD5010        Pubmed No.:32594052        PMCID:
  Details:
  Journal name:
• Analgesic effect of AG490, a Janus kinase inhibitor, on oxaliplatin-induced acute neuropathic pain
  Catalog No.:BS13278        Pubmed No.:30106061        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model
  Catalog No.:BS6067        Pubmed No.:33433498        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model
  Catalog No.:BS6000        Pubmed No.:33433498        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model
  Catalog No.:BS3590        Pubmed No.:33433498        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model
  Catalog No.:BS4633        Pubmed No.:33433498        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model
  Catalog No.:BS4781        Pubmed No.:33433498        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model
  Catalog No.:BS9811M        Pubmed No.:33433498        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model
  Catalog No.:BS91062        Pubmed No.:33433498        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model
  Catalog No.:BS7179        Pubmed No.:33433498        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model
  Catalog No.:BS70205        Pubmed No.:33433498        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model
  Catalog No.:BS2538        Pubmed No.:33433498        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model
  Catalog No.:BS4021        Pubmed No.:33433498        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model
  Catalog No.:BS9832M        Pubmed No.:33433498        PMCID:
  Details:
  Journal name:
• Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model
  Catalog No.:AP0768        Pubmed No.:33433498        PMCID:
  Details:
  Journal name: